![Suleman Aktaa Profile](https://pbs.twimg.com/profile_images/1575116072168079360/Afzz364C_x96.jpg)
Suleman Aktaa
@SulemanAktaa
Followers
624
Following
5K
Statuses
1K
MD | PhD | FESC | Outcome Research | @BCIS_UK Interventional & Structural Cardiology Fellow @UBCmedicine | Guidelines Committee @escardio
Vancouver, British Columbia
Joined December 2012
🌍 Geographical #Inequality in Access to Aortic Valve Intervention in England. A report from the UK #TAVI Registry & National Adult Cardiac Surgery Audit 🇬🇧 #TAVR #SAVR #CardioTwitter #Cardiology @radcliffeCARDIO #ICR³ @Ryvetsprog 📚 .
1
8
18
RT @BritishCardioSo: 💻 Catch up on our first webinar! 💻 We recently held the first in a series of BCS webinars; 'Current Challenges in Aor…
0
4
0
RT @RosselloXavier: 🔥 HOT OFF THE PRESS 📄 European Society of Cardiology quality indicators for the management of acute coronary syndrome.…
0
41
0
RT @DFCapodanno: TAVI has become a key alternative to surgical aortic valve replacement, supported by strong evidence from randomized trial…
0
51
0
RT @Dr_Noman_Ali: The TAVI complexity score: a novel scoring system which seperates patients into 3 levels of complexity that correlate wit…
0
12
0
RT @escardio: RHEIA trial: What is it? 48 clinical sites, more than 400 patients in 12 countries, with one common goal: evaluate safety and…
0
5
0
RT @escardio: #ESCCongress 2025 together with World Congress of Cardiology #WCCardio 🌎 Join us in Madrid, 29 August – 1 September, as we c…
0
21
0
RT @SCAI: 📖 Need a refresher on MitraClip? Check out our #TEER ebook for practical knowledge on how to perform this procedure. 🔗 https://t.…
0
8
0
RT @OPCILive: Don't miss the ONLY course in 2025 dedicated to structural complications | January 17 - January 18 at the luxurious Grand Ame…
0
4
0
RT @CurioJonathan: TOP LBTs @ #PCRLV 2024�� A concise 1 slide summary of all trials 4 those who cant be live at the main arena👀⤵️ @PamelaG…
0
28
0
RT @PCRonline: 🔥#PCRLV 🇬🇧 2024 Late-breaking Trials: Spotlight on COMPARE-TAVI A benchmark of the performance and safety of new THVs again…
0
22
0
RT @ESC_Journals: Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Car…
0
8
0
More from #EuroHeart ❗️ Definitions of key outcome measures for common #cardiovascular diseases & interventions #EHJ
@ESC_Journals @escardio #ClinicalTrials #TAVR
For this work we brought together a Global Cardiovascular Outcomes Consortium to develop & agree upon a suite definitions of clinical study outcome measures for cardiovascular diseases. Lots of work; grateful to all those who contributed. Read & use.
0
3
9
RT @cpgale3: 🤔, what can we learn from @NICEComms about the design, appraisal & implementation of #NHS indicators to improve quality of #…
0
2
0
RT @EuroInterventio: Redo-TAVI: Expanding the SAPIEN 3 valve within another SAPIEN (XT or S3) improves with pre- and post-dilatation, reach…
0
36
0
RT @igomezblazquez: Left Ventricular Embolization during TAVR for Pure Aortic Regurgitation: Arterio-arterial Loop as a Bailout Technique.…
0
44
0
RT @EuroInterventio: Redo-TAVI outcomes are influenced by initial TAV design, implantation depth, and neoskirt height, impacting coronary a…
0
68
0
RT @ramonlopezpalop: ACURATE IDE trial does not demonstrate non-inferiority of ACURATE NEO2 versus Control (EVOLVE and SAPIENS). https://t.…
0
2
0
RT @CMichaelGibson: INFINITY-SWEDEHEART analysis shows bioadaptor implant has low rates of target lesion failure at 12 months, non-inferior…
0
11
0
RT @mirvatalasnag: @PCRonline #LBCT #TCT2024 TAVR UNLOAD @drnvanmieghem @djc795 @hahn_rt @PPibarot et al TAVR was not superior to AS surv��
0
14
0